The entire team at Provantage were outstanding from start to finish. Without them, the deal simply would not have happened. As advisors on all the key aspects of the transaction, they were with me every step of the way from start to finish. I was particularly impressed with their accessibility at any time of the day or night, their ability to find solutions in challenging circumstances, and their tenacity and drive to get us to the finishing line. Their empathy, expertise and focus on relationships meant they were able to inspire me with total confidence. Their expertise was also coupled with a genuinely caring approach to the pressures the team were under during the process, and this was of great comfort when the inevitable challenges occurred. I cannot recommend them highly enough
- Share this:
Provantage Corporate Finance advises BioZone Scientific International, a global developer and manufacturer of ultraviolet technology in an MBO backed by leading mid-market private equity firm LDC
Project: Biozone Scientific International
Sector: Healthcare, TMT
Deal Value: undisclosed
Private Equity: LDC
BioZone Scientific International, Inc (BSI). is an innovator, developer and manufacturer of UV lighting solutions used in biological defence, disinfection, and sanitation systems for HVAC, Food Service and Hygiene Industries. BioZone has patented and market-leading products with clients across the UK, Europe, Asia-Pacific and North America. Its clients include multinational leisure and transport businesses.
The business now plans to accelerate sales in the US, open new in-country offices in other key territories and invest in the development of next-generation products.
Director Paul Morris, who becomes CEO as part of the transaction said, “For decades, BioZone’s UV light technology has been helping to improve the quality and safety of domestic and commercial spaces all over the world through better disinfection, sanitation and purification.”
John Green, Investment Director at LDC said, “BioZone is a genuinely world-class business that lacks the scale it deserves. Working closely with the management team and our non-executives, we’re looking forward to helping Paul accelerate take-up of its category-leading products in its chosen markets.”
The transaction was originated and led by David Browne and Alex Thompson of Provantage Corporate Finance
Alex Thompson, Provantage commented, “The partnership with LDC helps to further ensure that the business is extremely well-positioned within its expanding global markets. I’m delighted for Paul and for all of BioZone’s senior management team as they enter the next phase of growth.”
David Browne, Provantage added, “A fantastic global business in a great sector with an excellent management team. Proud and privileged to be involved. The partnership with LDC will help facilitate the realisation of its full potential on what has been and will be a very exciting journey. Very pleased that the transaction will lead to the wider deployment of proven air quality technology across the globe to help combat the impact of the pandemic”.